CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 77 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-26 | HARTOUNIAN HARTOUN Director | Grant or award · Stock Option (Right to Buy) | +225,000 | $0.70 | $158K | 225,000 |
| 2025-01-01 | HARTOUNIAN HARTOUN EVP, Chief Operating Officer | Grant or award | +50,000 | 52,000 | ||
| 2024-06-24 | HARTOUNIAN HARTOUN EVP, Chief Operating Officer | Grant or award | +30,000 | 30,000 | ||
| 2024-06-24 | HARTOUNIAN HARTOUN EVP, Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 |
Page 1 of 1 · 4 trades